SNY Sanofi
- 47.150
- +0.850+1.84%
- 47.160
- +0.010+0.02%
Sanofi News
UBS Keeps Their Buy Rating on Sanofi (SNYNF)
Analysts Conflicted on These Healthcare Names: Intra-Cellular Therapies (ITCI), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
Maintaining Buy Rating on Sanofi: A Resilient Financial Outlook Despite Currency Headwinds
Barclays Sticks to Its Buy Rating for Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Sanofi (OtherSNYNF)
Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Molina Healthcare (MOH) and Aura Biosciences Inc (AURA)
Sanofi's Buy Rating Affirmed by Analyst on Strong Clinical Trials and Market Opportunities
Teva Upgraded at J.P. Morgan on Upcoming Catalysts
Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN), Sanofi (OtherSNYNF) and Moderna (MRNA)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), Laboratory (LH) and Organon (OGN)
Federated Hermes Equities CIO: The Bull Market Has Just Started
Sanofi Growth Prospects and Pipeline Potential Affirm Buy Rating
Deutsche Bank Sticks to Its Sell Rating for Sanofi (SNYNF)
UBS Sticks to Their Buy Rating for Sanofi (SNYNF)
Buy Rating Affirmed for Sanofi on Strong Sales and Promising Financial Outlook
Analysts Have Conflicting Sentiments on These Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Calliditas Therapeutics (CALT) and Sanofi (OtherSNYNF)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT), Sanofi (OtherSNYNF) and Siemens Healthineers AG (OtherSEMHF)
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
Analysis
Price Target
No Data
